This study was supported by a grant from the Province Natural Science Foundation of Shandong (No. Y2007C 148).
Background The prognosis is poor for patients with relapsed or refractory non-Hodgkin's lymphoma (NHL). The main reason for poor prognosis is multidrug resistance (MDR), for which the main phenotype is overexpres...